MX9306879A - Derivados de piperazina y composiciones farmaceuticas que los contienen,para el tratamiento de enfermedades del conocimiento. - Google Patents

Derivados de piperazina y composiciones farmaceuticas que los contienen,para el tratamiento de enfermedades del conocimiento.

Info

Publication number
MX9306879A
MX9306879A MX9306879A MX9306879A MX9306879A MX 9306879 A MX9306879 A MX 9306879A MX 9306879 A MX9306879 A MX 9306879A MX 9306879 A MX9306879 A MX 9306879A MX 9306879 A MX9306879 A MX 9306879A
Authority
MX
Mexico
Prior art keywords
derivatives
treatment
piperazine
diseases
knowledge
Prior art date
Application number
MX9306879A
Other languages
English (en)
Spanish (es)
Inventor
Ian Anthony Cliffe
Allan Fletcher
Alan Chapman White
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Publication of MX9306879A publication Critical patent/MX9306879A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
MX9306879A 1992-11-05 1993-11-04 Derivados de piperazina y composiciones farmaceuticas que los contienen,para el tratamiento de enfermedades del conocimiento. MX9306879A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929223153A GB9223153D0 (en) 1992-11-05 1992-11-05 Piperazine derivatives

Publications (1)

Publication Number Publication Date
MX9306879A true MX9306879A (es) 1995-01-31

Family

ID=10724559

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9306879A MX9306879A (es) 1992-11-05 1993-11-04 Derivados de piperazina y composiciones farmaceuticas que los contienen,para el tratamiento de enfermedades del conocimiento.

Country Status (18)

Country Link
US (1) US5827847A (enExample)
EP (1) EP0877612B1 (enExample)
JP (1) JP3238153B2 (enExample)
AT (1) ATE195422T1 (enExample)
AU (1) AU682155B2 (enExample)
CA (1) CA2148593C (enExample)
DE (1) DE69329252T2 (enExample)
DK (1) DK0877612T3 (enExample)
ES (1) ES2149216T3 (enExample)
GB (1) GB9223153D0 (enExample)
GR (1) GR3034400T3 (enExample)
HU (1) HUT72049A (enExample)
LV (1) LV12734B (enExample)
MX (1) MX9306879A (enExample)
PT (1) PT877612E (enExample)
TW (1) TW252043B (enExample)
WO (1) WO1994009780A1 (enExample)
ZA (1) ZA937827B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0710481A1 (en) * 1994-11-02 1996-05-08 Duphar International Research B.V Use of flesinoxan for cognition enhancement
US6271234B1 (en) * 1997-08-01 2001-08-07 Recordati S.A., Chemical And Pharmaceutical Company 1,4-disubstituted piperazines

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2355502A1 (fr) * 1976-06-23 1978-01-20 Roussel Uclaf Application a titre de medicaments d'un derive de la piperazine et de ses sels
US4423049A (en) * 1981-12-28 1983-12-27 Mead Johnson & Company 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyrimidines
GB2222768B (en) * 1988-06-17 1992-01-22 Nat Res Dev Analgesic compounds and compositions
GB8909209D0 (en) * 1989-04-22 1989-06-07 Wyeth John & Brother Ltd Piperazine derivatives
US4902687A (en) * 1989-03-27 1990-02-20 Eli Lilly And Company Excitatory amino acid receptor antagonists
EP0955296A3 (en) * 1989-04-22 2000-01-19 American Home Products Corporation Tertiary alkyl functionalized piperazine derivatives
IL94151A (en) * 1989-04-22 1995-08-31 Wyeth John & Brother Ltd History of piperazine, their preparation and pharmaceutical preparations containing them
EP0398413A1 (en) * 1989-05-16 1990-11-22 Duphar International Research B.V "3,4-dehydropiperidine derivatives having psychotropic activity
ATE178893T1 (de) * 1990-01-11 1999-04-15 Upjohn Co 6,7,8,9-tetrahydro-3h-benz(e)indolheterocyclen mit wirkung auf das zentrale nervensystem
GB9022820D0 (en) * 1990-10-19 1990-12-05 Wyeth John & Brother Ltd Piperazine derivatives
DE4039631A1 (de) * 1990-12-12 1992-06-17 Troponwerke Gmbh & Co Kg Neuroprotektive kombination
MX9201991A (es) * 1991-05-02 1992-11-01 Jonh Wyeth & Brother Limited Derivados de piperazina y procedimiento para su preparacion.
DE4135551A1 (de) * 1991-08-31 1993-03-04 Schering Ag Verwendung von antagonisten oder partiellen agonisten am 5-ht1a-rezeptor zur behandlung und praevention von kognitiven stoerungen

Also Published As

Publication number Publication date
AU682155B2 (en) 1997-09-25
AU5342194A (en) 1994-05-24
HUT72049A (en) 1996-03-28
JP3238153B2 (ja) 2001-12-10
US5827847A (en) 1998-10-27
DE69329252D1 (de) 2000-09-21
ATE195422T1 (de) 2000-09-15
EP0877612A1 (en) 1998-11-18
CA2148593A1 (en) 1994-05-11
PT877612E (pt) 2000-11-30
DK0877612T3 (da) 2000-10-09
WO1994009780A1 (en) 1994-05-11
JPH08502743A (ja) 1996-03-26
DE69329252T2 (de) 2001-03-29
EP0877612B1 (en) 2000-08-16
LV12734A (en) 2001-10-20
GR3034400T3 (en) 2000-12-29
GB9223153D0 (en) 1992-12-16
LV12734B (en) 2002-01-20
HU9501290D0 (en) 1995-06-28
CA2148593C (en) 2005-12-06
ES2149216T3 (es) 2000-11-01
ZA937827B (en) 1995-04-21
TW252043B (enExample) 1995-07-21

Similar Documents

Publication Publication Date Title
ES2116801T3 (es) Empleo de derivados de adamantano para el tratamiento de tinnitus.
ATE94384T1 (de) Verwendung von adamantan-derivaten zur praevention und behandlung der cerebralen ischaemie.
NO306344B1 (no) Nye sulfonamider, anvendelse derav og farmasöytiske preparater inneholdende dem
FI964772A0 (fi) (a)-annelloidut pyrrolijohdannaiset ja niiden käyttö farmasiassa
DE60107435D1 (de) 2-adamantylethylamine und deren verwendung bei der behandlung von abnormalitäten in der glutamat transmission
ES2098023T3 (es) Compuestos de estructura guanidinica y composiciones farmaceuticas que los contienen.
DE69424009D1 (de) Verwendung von (S)-(-)-alpha-ethyl-2-oxo-1-pyrrolidinacetamid zur Herstellung eines Medikaments zur Behandlung von Angst
MX9400253A (es) Derivados de piperazina, proceso para su preparacion y composiciones farmaceuticas que los contienen.
ES2103440T3 (es) Nuevas amidas y sulfonamidas naftalenicas, procedimiento de preparacion y composiciones farmaceuticas que las contienen.
NO172640C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive piperazinderivater
DE69525633D1 (de) Chinoxalinderivate und ihre therapeutische verwendbarkeit
DK0646110T3 (da) N-substituerede 3-azabicyclo(3.2.0) heptanderivater som neuroleptika
ES2094638T3 (es) N-acilpirrolidinas y medicamentos para el tratamiento o la prevencion de los desordenes relacionados con la colecistoquinina y la gastrina.
ATE223379T1 (de) N-aryloxyethylaminderivate zur behandlung der depression
ES2149216T3 (es) Utilizacion de derivados de piperazina para el tratamiento de trastornos cognoscitivos.
ES2094048T3 (es) N-acilpirrolidinas y medicamentos para el tratamiento o la prevencion de los desordenes relacionados con la colecistoquinina y la gastrina.
DK0625982T3 (da) 4-Oxo- og 4H-imidazo(5,1-c)(1,4)benzoxaziner anvendelige som benzodiazepinreceptor-bindemidler
DE59409813D1 (de) Imidazolochinoxalinone zur behandlung zentralnervöser erkrankungen
ATE125531T1 (de) 1-phenylpiperid-4-ylamine und diese enthaltende arzneimittel.
DE59309469D1 (de) Triazolochinazoline zur behandlung zentralnervöser erkrankungen
ATE167873T1 (de) Neue heterocyclische acyldipeptide, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung
IL107915A (en) N-substituted azabicycloheptane derivatives and their use as medicaments

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees